• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续性非卧床腹膜透析(CAPD)患者透析液中促红细胞生成素测定的准确性

Accuracy of erythropoietin determination in the dialysate of CAPD patients.

作者信息

Struijk D G, Koomen G C, Krediet R T, Arisz L

机构信息

Department of Medicine, University of Amsterdam, The Netherlands.

出版信息

Adv Perit Dial. 1990;6:289-91.

PMID:1982829
Abstract

In vitro experiments were performed to analyze problems with the determination of erythropoietin in dialysate. Human recombinant erythropoietin (EPO; 4000 U/L) was added to several fluids, to glass or polystyrene tubes with or without addition of bovine serum albumin (BSA) and to dialysate bags. The recovery in peritoneal effluent was 4120 +/- 203 U/L (mean +/- SEM). The recovery in the other fluids was less than 50% but in glass tubes it increased to 96% after addition of BSA. Binding was also found to the dialysate bag, therefore reducing the amount available for absorption. We recommend that EPO samples from the dialysate are drawn within BSA coated glass tubes.

摘要

进行体外实验以分析透析液中促红细胞生成素测定的相关问题。将人重组促红细胞生成素(EPO;4000 U/L)添加到几种液体中、添加或不添加牛血清白蛋白(BSA)的玻璃或聚苯乙烯管中以及透析袋中。腹腔流出液中的回收率为4120±203 U/L(平均值±标准误)。其他液体中的回收率低于50%,但在玻璃管中添加BSA后回收率增至96%。还发现透析袋存在结合现象,从而减少了可供吸收的量。我们建议在涂有BSA的玻璃管内采集透析液中的EPO样本。

相似文献

1
Accuracy of erythropoietin determination in the dialysate of CAPD patients.持续性非卧床腹膜透析(CAPD)患者透析液中促红细胞生成素测定的准确性
Adv Perit Dial. 1990;6:289-91.
2
Intraperitoneal production of erythropoietin with continuous ambulatory peritoneal dialysis.
Pediatr Nephrol. 1993 Jun;7(3):281-3. doi: 10.1007/BF00853222.
3
Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.持续性非卧床腹膜透析患者皮下及腹腔注射重组人促红细胞生成素的药代动力学和药效学
Clin Nephrol. 1990 Jan;33(1):47-51.
4
The pharmacokinetics of intraperitoneal erythropoietin administered undiluted or diluted in dialysate.腹腔内注射未稀释或在透析液中稀释的促红细胞生成素的药代动力学。
Perit Dial Int. 1992;12(4):369-72.
5
Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.皮下注射促红细胞生成素治疗持续性非卧床腹膜透析患者贫血的间歇性给药方案
Adv Perit Dial. 1993;9:331-5.
6
Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.腹膜转运状态对持续性非卧床腹膜透析患者动脉粥样硬化/炎症的影响。
J Ren Nutr. 2005 Oct;15(4):427-34. doi: 10.1053/j.jrn.2005.07.007.
7
Binding of insulin to a continuous ambulatory peritoneal dialysis system.
Am J Hosp Pharm. 1986 Jan;43(1):81-8.
8
Inflammation, peritoneal transport, and response to erythropoietin in peritoneal dialysis patients.腹膜透析患者的炎症、腹膜转运及对促红细胞生成素的反应
Adv Perit Dial. 2001;17:153-7.
9
Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).持续非卧床腹膜透析(CAPD)患者血清、透析液、尿液和骨骼中的铝浓度。
Clin Nephrol. 1989 Sep;32(3):133-8.
10
Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.在接受重组人促红细胞生成素治疗的持续性非卧床腹膜透析或持续性循环腹膜透析患者中使用大剂量腹腔内右旋糖酐铁。
Adv Perit Dial. 1999;15:60-4.

引用本文的文献

1
Pharmacokinetics of recombinant human erythropoietin in children treated with continuous ambulatory peritoneal dialysis.
Eur J Pediatr. 1994 Nov;153(11):850-4. doi: 10.1007/BF01972896.